Bayer says it has not been asked by US to negotiate drug prices
FRANKFURT, April 24 (Reuters) - The head of Bayer's BAYGn.DE pharmaceuticals division told the group's shareholders at their annual meeting on Friday that the U.S. government had so far not formally asked Bayer to negotiate drug prices. (Reporting by Patricia Weiss Writing by Ludwig Burger Editing by Miranda Murray) ((ludwig.burger@thomsonreuters.com;))
Recent news on Bayer AG
See all newsBayer takes a giant leap toward investability
Europe Research Roundup: Barratt Redrow, Ferrari, KPN
Explainer: What does Bayer's US Supreme Court win mean for the thousands of Roundup lawsuits?
Bayer shares soar over 18% after U.S. Supreme Court curbs Roundup lawsuits
US Supreme Court scales back Roundup cancer suits in win for Bayer (updated)